Search

everythinglearnresearchcommunity

for

Search:↓

Facial hair is crucial for transgender men's gender identity and transition.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Adding estrogen increased bone mass in a transsexual man undergoing hormone therapy.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Testosterone treatment may affect heart response to stress in transgender men.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Facial aesthetic procedures improve quality of life for transgender individuals.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.